In recurrent NPC, to maintain immune escape, these high Galectin-9 expressing NPC cells maintains their ability to inactivate the survival and growth of tumour-infiltrating CD8+ lymphocytes. The gene discussed is LGALS9; the disease is nasopharyngeal carcinoma.